Capricor Therapeutics, Inc. News

Recent verified news about Capricor Therapeutics, Inc. (CAPR), including story sentiment and market listing information.

• FDA panel votes 9-3 against Duchenne heart therapy
• Capricor shares fall 70% after FDA questions efficacy

FDA panel votes 9-3 against Duchenne heart therapy

A U.S. Food and Drug Administration advisory panel voted on Wednesday, July 29, against recommending approval of an investigational cell therapy for a heart condition associated with Duchenne muscular dystrophy, citing i...

Mainstream Bias 4 Sources

Left 25% Neutral 50% Right 25%

3 days agohealth

Capricor shares fall 70% after FDA questions efficacy

Shares of Capricor Therapeutics plummeted as much as 70% on Monday, July 27, 2026, after U.S. Food and Drug Administration staff released critical briefing documents questioning the effectiveness of the company's experim...

Mainstream Bias 7 Sources

Left 0% Neutral 86% Right 14%

5 days agobusinessUS